Cargando…
Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma
BACKGROUND: Known as solid tumors of intermediate malignant potential, most inflammatory myofibroblastic tumors (IMTs) are treatable as long as the tumor is en-bloc resected. However, in some cases, the tumors have recurred and grown rapidly after successful surgery. Some of these tumors were classi...
Autores principales: | Jiang, Quan, Tong, Han-Xing, Hou, Ying-Yong, Zhang, Yong, Li, Jing-Lei, Zhou, Yu-Hong, Xu, Jing, Wang, Jiong-Yuan, Lu, Wei-Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442869/ https://www.ncbi.nlm.nih.gov/pubmed/28535796 http://dx.doi.org/10.1186/s13023-017-0647-8 |
Ejemplares similares
-
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
por: Li, Mengmeng, et al.
Publicado: (2023) -
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
por: Xu, Xiaojing, et al.
Publicado: (2019) -
A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene
por: Muscarella, Lucia Anna, et al.
Publicado: (2017) -
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma
por: Fordham, Ashleigh M., et al.
Publicado: (2020) -
Epithelioid inflammatory myofibroblastic sarcoma: the youngest case reported
por: Batool, Sajida, et al.
Publicado: (2021)